BC

Bodele Charandas Dhammadip

Active Director Director DIN 07685152
DIN 07685152 First appointment Apr 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Bodele Charandas Dhammadip

Data last updated:

Bodele Charandas Dhammadip is a Director at Nucleon Lifecare Pharma Private Limited (since 2017). The company operates in Business Services.

DIN 07685152
Primary Designation Director
Industry Business Services
First Appointment 28 Apr 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20172017Under Process Of Striking Off

Board colleagues of Bodele Charandas Dhammadip

Directorship timeline

Open interactive timeline →
Nucleon Lifecare Pharma Private Limited
Premium access

Shareholding and investment profile for Bodele Charandas Dhammadip

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bodele Charandas Dhammadip

Bodele Charandas Dhammadip currently holds 1 directorship: Nucleon Lifecare Pharma Private Limited (Director, since 28 Apr 2017).

Bodele Charandas Dhammadip was first appointed on 28 Apr 2017 as Director at Nucleon Lifecare Pharma Private Limited.

The current boards of Bodele Charandas Dhammadip's companies include Anuj Bodele Charandas (Nucleon Lifecare Pharma Private Limited), Vijay Babaji Urade (Nucleon Lifecare Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available